Heidelberg, Germany

Erik Jung

This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Dc Europa Limited, Universitat Heidelberg. Active years: 2022-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Erik Jung. Retrieved from https://idiyas.com/inventor/erik-jung-saz8nei2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2022-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Erik Jung

Introduction

Erik Jung is a notable inventor based in Heidelberg, Germany. He has made significant contributions to the field of medical treatments, particularly in the area of glioma. With a total of 2 patents, his work focuses on developing agents for the treatment of various types of glioma.

Latest Patents

Erik Jung's latest patents include innovative agents designed for the treatment of glioma. The first patent addresses agents for use in the treatment of glioma, specifically targeting astrocytoma WHO II° and III°, as well as IV° (glioblastoma). The second patent similarly relates to agents for the treatment of glioma, focusing on astrocytoma WHO I° and III°, along with IV° (glioblastoma). These inventions aim to provide new therapeutic options for patients suffering from these challenging conditions.

Career Highlights

Throughout his career, Erik Jung has worked with prestigious institutions, including the University of Heidelberg and Dc Europa Limited. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of Erik Jung's notable coworkers include Matthias Osswald and Wolfgang Wick. Their collaborative efforts have further advanced the research and development of treatments for glioma.

Conclusion

Erik Jung's contributions to the field of glioma treatment through his patents and collaborations highlight his dedication to medical innovation. His work continues to pave the way for new therapeutic strategies in combating this serious disease.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…